Cancer glossary
Chemotherapy regimens: what FOLFOX, FOLFIRI, CAPOX and AC mean
How to decode the chemotherapy regimen in your records: which drugs make up FOLFOX, FOLFIRI, CAPOX and AC, and what the numbers and the letter m mean.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
A chemotherapy regimen is a treatment plan that sets the drugs, doses, order and intervals between treatments. Regimens are usually named with abbreviations built from the drug names, so a record says ‘FOLFOX’ rather than listing three medicines.
How it appears in your report
- ‘Chemotherapy with mFOLFOX6, 4 cycles’ — FOLFOX in its modified FOLFOX-6 version, 4 cycles given.
- ‘4 cycles of AC, followed by paclitaxel’ — the AC regimen, then another drug given in sequence.
- ‘CAPOX (XELOX)’ — two names for the same drug combination.
- ‘First line: FOLFIRI + targeted agent’ — an antibody added to chemotherapy; the line number shows which treatment this is in sequence.
What it means
The most common regimens, as defined in the US National Cancer Institute dictionary:
| Regimen | Drugs (generic names) | Where it is used most |
|---|---|---|
| FOLFOX | leucovorin (folinic acid), fluorouracil, oxaliplatin | colorectal cancer |
| FOLFIRI | leucovorin, fluorouracil, irinotecan | advanced colorectal cancer |
| CAPOX / XELOX | capecitabine, oxaliplatin | colorectal cancer |
| AC | doxorubicin, cyclophosphamide | breast cancer |
Leucovorin is a form of folic acid; the National Cancer Institute classes it, among other things, as an agent that enhances the effect of chemotherapy. The numbers and the letter m in a name (FOLFOX-4, FOLFOX-6, mFOLFOX-6) mark versions that differ in doses and in how the drugs are given.
Does it affect treatment
The regimen determines the rhythm of treatment (how often drugs are given), whether a port is needed for long infusions, and which side effects to expect. For example, oxaliplatin can cause neuropathy, and some regimens have their own blood count thresholds before a cycle. If side effects reach a significant CTCAE grade, the doctor may delay a cycle, lower a dose or drop a drug. Choosing or changing a regimen is a decision for your treating doctor or a tumor board.
Questions to ask your doctor
- What is the full name of my regimen, and which drugs are in it?
- How far apart are the cycles, and how many are planned?
- Which side effects should I expect from each drug, and when should I call you?
How a cycle works step by step is covered in the article on chemotherapy. If you want to check whether the planned regimen fits your case, I can review your records for a second opinion.
Sources
- FOLFOX — NCI Dictionary of Cancer Terms — National Cancer Institute
- AC — NCI Dictionary of Cancer Terms — National Cancer Institute
- Drugs Approved for Colon and Rectal Cancer — National Cancer Institute, 2026
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
